Covid-19 vaccine: 5 things to know about Pfizer’s encouraging trial results – Hindustan Times
Pfizer Inc. and BioNTech SE on Wednesday announced that the final efficacy analysis of its vaccine candidate, BNT162b2, undergoing Phase 3 trial met all of the study’s primary efficacy endpoints. T…
